1.Lymphoepithelioma-like Carcinoma of the Renal Pelvis: A Case Report and Review of the Literature.
Hyein AHN ; Jongmin SIM ; Hyunsung KIM ; Kijong YI ; Hulin HAN ; Yumin CHUNG ; Abdul REHMAN ; Seung Sam PAIK
Korean Journal of Pathology 2014;48(6):458-461
No abstract available.
Kidney Pelvis*
2.Effects of Cryopreservation and Thawing on Single-Cell Transcriptomes of Human T Cells
Jeong Seok LEE ; Kijong YI ; Young Seok JU ; Eui-Cheol SHIN
Immune Network 2020;20(4):e34-
Cryopreservation and thawing of PBMCs are inevitable processes in expanding the scale of experiments in human immunology. Here, we carried out a fundamental study to investigate the detailed effects of PBMC cryopreservation and thawing on transcriptomes. We sorted Tregs from fresh and cryopreserved/thawed PBMCs from an identical donor and performed single-cell RNA-sequencing (scRNA-seq). We found that the cryopreservation and thawing process minimally affects the key molecular features of Tregs, including FOXP3. However, the cryopreserved and thawed sample had a specific cluster with up-regulation of genes for heat shock proteins. Caution may be warranted in interpreting the character of any cluster of cells with heat shock-related properties when cryopreserved and thawed samples are used for scRNA-seq.
3.Clinicopathological Significance of Dual-Specificity Protein Phosphatase 4 Expression in Invasive Ductal Carcinoma of the Breast.
Hyunsung KIM ; Se Min JANG ; Hyein AHN ; Jongmin SIM ; Kijong YI ; Yumin CHUNG ; Hulin HAN ; Abdul REHMAN ; Min Sung CHUNG ; Kiseok JANG ; Seung Sam PAIK
Journal of Breast Cancer 2015;18(1):1-7
PURPOSE: Dual-specificity protein phosphatase 4 (DUSP4), also known as mitogen-activated protein kinase phosphatase (MKP) 2 is a member of the inducible nuclear MKP group. The role of DUSP4 in cancer development and progression appears to vary with the type of malignancy. The purpose of this study was to investigate DUSP4 expression in a case series of invasive ductal carcinoma of the breast. METHODS: We constructed tissue microarrays consisting of 16, 14, 47, and 266 cases of normal breast tissue, usual ductal hyperplasia, ductal carcinoma in situ, and invasive ductal carcinoma, respectively. DUSP4 expression was investigated by immunohistochemistry. RESULTS: Cytoplasmic DUSP4 expression was observed. DUSP4 was more frequently expressed in malignant than in benign cases (p=0.024). The mean DUSP4 expression score was significantly higher in malignant tumors than in benign lesions (p=0.019). DUSP4 expression was significantly correlated with a larger tumor size (>2 cm, p=0.015). There was no significant correlation between overall survival or disease-free survival and DUSP4 expression in all 266 patients. We evaluated the impact of DUSP4 expression on the survival of 120 patients with T1-stage tumors. Interestingly, Kaplan-Meier survival curves revealed that DUSP4 expression had a significant effect on both overall patient survival (p=0.034, log-rank test) and disease-free survival (p=0.045, log-rank test). In early T-stage breast cancer, DUSP4 expression was associated with a worse prognosis. CONCLUSION: DUSP4 is frequently upregulated in breast malignancy, and may play an important role in cancer development and progression. In addition, it may be a marker of adverse prognosis, especially in patients with early T1-stage cancer.
Breast Neoplasms
;
Breast*
;
Carcinoma, Ductal*
;
Carcinoma, Intraductal, Noninfiltrating
;
Cytoplasm
;
Disease-Free Survival
;
Humans
;
Hyperplasia
;
Immunohistochemistry
;
Kaplan-Meier Estimate
;
Prognosis
;
Protein Kinases
4.Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma.
Kijong YI ; Hyunsung KIM ; Yumin CHUNG ; Hyein AHN ; Jongmin SIM ; Young Chan WI ; Ju Yeon PYO ; Young Soo SONG ; Seung Sam PAIK ; Young Ha OH
Journal of Pathology and Translational Medicine 2016;50(5):327-336
BACKGROUND: Developing predictive markers for hepatocellular carcinoma (HCC) is important, because many patients experience recurrence and metastasis. Epithelial to mesenchymal transition (EMT) is a developmental process that plays an important role during embryogenesis and also during cancer metastasis. Paired-related homeobox protein 1 (Prrx-1) is an EMT inducer that has recently been introduced, and its prognostic significance in HCC is largely unknown. METHODS: Tissue microarray was constructed using surgically resected primary HCCs from 244 cases. Immunohistochemical staining of E-cadherin and Prrx-1 was performed. The correlation between E-cadherin loss and Prrx-1 expression, as well as other clinicopathologic factors, was evaluated. RESULTS: E-cadherin expression was decreased in 96 cases (39.4%). Loss of E-cadherin correlated with a higher recurrence rate (p < .001) but was not correlated with patient's survival. Thirty-two cases (13.3%) showed at least focal nuclear Prrx-1 immunoreactivity while all non-neoplastic livers (n = 22) were negative. Prrx-1 expression was not associated with E-cadherin loss, survival or recurrence rates, pathologic factors, or the Ki-67 labeling index. Twenty tumors that were positive for E-cadherin and Prrx-1 had significantly higher nuclear grades than the rest of the cohort (p = .037). In Cox proportional hazard models, E-cadherin loss and large vessel invasion were independent prognostic factors for shorter disease-free survival. Cirrhosis and high Ki-67 index (> 40%) were independent prognostic factors for shorter overall survival. CONCLUSIONS: Prrx-1 was expressed in small portions of HCCs but not in normal livers. Additional studies with a large number of Prrx-1-positive cases are required to confirm the results of this study.
Cadherins*
;
Carcinoma, Hepatocellular*
;
Cohort Studies
;
Disease-Free Survival
;
Embryonic Development
;
Epithelial-Mesenchymal Transition
;
Female
;
Fibrosis
;
Genes, Homeobox
;
Humans
;
Liver
;
Neoplasm Metastasis
;
Pregnancy
;
Proportional Hazards Models
;
Recurrence
5.Wnt7a Deficiency Could Predict Worse Disease-Free and Overall Survival in Estrogen Receptor-Positive Breast Cancer.
Kijong YI ; Kyueng Whan MIN ; Young Chan WI ; Yeseul KIM ; Su Jin SHIN ; Min Sung CHUNG ; Kiseok JANG ; Seung Sam PAIK
Journal of Breast Cancer 2017;20(4):361-367
PURPOSE: Wnt7a is a glycoprotein involved in embryonic development and the progression of different types of malignant tumors. This study aimed to detect the level of Wnt7a expression in breast cancer and explore its role in the disease progression and prognosis. METHODS: A total of 258 patients diagnosed with invasive ductal carcinoma of the breast were included in this study. Using tissue microarray and immunohistochemical staining, we evaluated the association between Wnt7a expression and clinicopathological parameters, and the prognostic value of Wnt7a. RESULTS: Wnt7a expression was significantly correlated with estrogen receptor (ER) expression (odds ratio, 3.95; 95% confidence interval [CI], 1.99–7.80; p < 0.001). On univariate and multivariate analyses, loss of Wnt7a expression was associated with poor disease-free survival (DFS) (multivariate hazard ratio [HR], 9.12; 95% CI, 1.80–46.09; p=0.008), but not with poor overall survival (OS). In the ER-positive group (n=114), loss of Wnt7a expression was an independent prognostic factor for shorter DFS (multivariate HR, 13.54; 95% CI, 1.11–165.73; p=0.042) and OS (multivariate HR, 4.76; 95% CI, 1.29–17.61; p=0.019) on univariate and multivariate analyses. However, in the ER-negative group, there was no significant difference in DFS and OS according to Wnt7a expression. CONCLUSION: The loss of Wnt7a expression might be a meaningful factor in assessing DFS and OS, especially in ER-positive breast cancer.
Breast Neoplasms*
;
Breast*
;
Carcinoma, Ductal
;
Disease Progression
;
Disease-Free Survival
;
Embryonic Development
;
Estrogens*
;
Female
;
Glycoproteins
;
Humans
;
Multivariate Analysis
;
Pregnancy
;
Prognosis
;
Receptors, Estrogen
;
Wnt Proteins